PENN up +4.79% percent right now. $PENN High is at 13.87

New Post Public Reply Private Reply Replies (0) Message Board

Nov 11, 2014 at 3:37 PM

PENN up +4.79% percent right now. $PENN High is at 13.87 and the Low 13.06 with current volume of 913,864.

Recent News posted below.

PENN Penn National Gaming Recent Headline News

Benefits of falling oil prices outweigh harm to energy sector, Barclays says
Seeking Alpha - at Seeking Alpha - Sat Nov 08, 8:25AM CST

BERY: 26.64 (-0.22), FDX: 171.78 (+0.04), MMM: 156.98 (-0.68), KSS: 56.03 (-0.54), HD: 98.00 (-0.16), KR: 58.29 (-0.27), CLX: 101.13 (-0.54), KMB: 113.16 (-0.76), AGCO: 45.17 (-0.07), AXL: 20.05 (+0.12), WMT: 78.94 (-0.50), WMS: 23.19 (+0.97), BWLD: 162.09 (+2.86), UPS: 108.76 (-0.29), VAL: 84.57 (+0.18), SAVE: 78.85 (-0.20), PENN: 13.94 (+0.79), CHH: 53.43 (+0.76), MHK: 142.89 (+0.18), TGT: 65.50 (-0.02), DE: 88.52 (-0.02), AAL: 43.62 (-0.21), DPZ: 91.53 (-0.55), GM: 31.39 (+0.27), SHW: 237.34 (+0.62), BLMN: 21.20 (-0.15), PPG: 204.90 (-1.37)

Uptrend Call Working As Penn National Gaming Stock Rises 13.7% (PENN)
Comtex SmarTrend(R) - Thu Nov 06, 11:14AM CST
SmarTrend identified an Uptrend for Penn National Gaming (NASDAQ

ENN) on September 8th, 2014 at $11.79. In approximately 2 months, Penn National Gaming has returned 13.70% as of today's recent price of $13.40.
PENN: 13.94 (+0.79)

Pinnacle to Spin Off REIT at Activist Investor Orange Capital's Behest
at The Street - Thu Nov 06, 10:15AM CST
Casino operator doesn't expect to complete REIT separation until 2016.
PNK: 22.55 (+0.01), PENN: 13.94 (+0.79), BEE: 12.73 (+0.06), GLPI: 31.82 (+0.10)

Update: Boyd Gaming Q3 Earnings Are Meh, But REIT Potential Sparks Interest
Marshall Hargrave - at Seeking Alpha - Wed Nov 05, 8:57AM CST

PENN: 13.94 (+0.79), BYD: 11.78 (+0.17)

Casinos and Gaming Stocks Technical Data - International Game Technology, Scientific Games, Pinnacle Entertainment, Bally Technologies, and Penn National Gaming
PR Newswire - Tue Nov 04, 7:30AM CST
Investor-Edge has initiated coverage on the following equities: International Game Technology (NYSE: IGT), Scientific Games Corporation (NASDAQ: SGMS), Pinnacle Entertainment Inc. (NYSE: PNK), Bally Technologies Inc. (NYSE: BYI), and Penn National Gaming Inc. (NASDAQ: PENN). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Monday, November 03, 2014, the NASDAQ Composite ended at 4,638.91, up 0.18%, the Dow Jones Industrial Average edged 0.14% lower to finish the day at 17,366.24, and the S&P 500 closed at 2,017.81, down 0.01%. The gains were broad based as seven out of ten sectors ended the session in positive. The S&P 500 Consumer Discretionary Sector Index ended the day at 540.05, up 0.02%, with the index also advancing 3.79% in the previous three months. Register for your complimentary reports on these five stocks at:
PENN: 13.94 (+0.79), PNK: 22.55 (+0.01), SGMS: 13.72 (+0.85), BYI: 80.92 (+0.50), IGT: 16.85 (+0.30)

Penn National Gaming Has Returned 9.2% Since SmarTrend Recommendation (PENN)
Comtex SmarTrend(R) - Thu Oct 30, 10:03AM CDT
SmarTrend identified an Uptrend for Penn National Gaming (NASDAQ

ENN) on September 8th, 2014 at $11.79. In approximately 2 months, Penn National Gaming has returned 9.21% as of today's recent price of $12.87.
PENN: 13.94 (+0.79)

The Zacks Analyst Blog Highlights: Penn National Gaming, Monarch Casino & Resort, Full House Resorts and Caesars Entertainment
PR Newswire - Tue Oct 28, 8:36AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Penn National Gaming Inc. (Nasdaq

ENN-Free Report), Monarch Casino & Resort Inc. (Nasdaq:MCRI-Free Report), Full House Resorts Inc. (Nasdaq:FLL-Free Report) and Caesars Entertainment Corp. (Nasdaq:CZR-Free Report).
FLL: 1.26 (-0.04), PENN: 13.94 (+0.79), MCRI: 16.88 (+0.29)

Earnings Estimates Moving Higher for Penn National Gaming (PENN): Time to Buy? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 7:56AM CDT
Penn National Gaming has decent short-term momentum and it is seeing solid activity on the earnings estimate revision front as well
PENN: 13.94 (+0.79)

Activist Investors on Quest to Find 'Magical' Properties
at The Street - Mon Oct 27, 2:47PM CDT
Investors seeking to unlock value in restaurant companies are increasingly calling for real estate assets to be spun off.
PNK: 22.55 (+0.01), PENN: 13.94 (+0.79), LTM: 56.46 (-0.29), CXW: 36.33 (-0.41), TGT: 65.50 (-0.02), IRM: 37.64 (unch), ARCP: 8.65 (+0.15), DRI: 55.75 (+1.44)

Gambling Stock Roundup: Penn National & Monarch Casino Beat Earnings, Full House Resorts Considers Sale; Macau Still a Concern - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 12:25PM CDT
Penn National Gaming Inc. (PENN) and Monarch Casino & Resort Inc. (MCRI) posted better than expected third quarter 2014 results while Full House Resorts Inc. (FLL) management is considering the sale of the company.
FLL: 1.26 (-0.04), PENN: 13.94 (+0.79), BYD: 11.78 (+0.17), MCRI: 16.88 (+0.29), LVS: 61.44 (+1.96), CZR: 10.97 (-0.57), MGM: 22.48 (+0.34)

Is Marriott International (MAR) Poised to Beat Q3 Earnings? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 23, 3:45PM CDT
Marriott International, Inc. (MAR) is set to report third quarter 2014 results on Oct 28, 2014.
PENN: 13.94 (+0.79), PNK: 22.55 (+0.01), DIS: 89.84 (+0.06), MAR: 77.16 (+0.60)

Penn National Gaming's (PENN) CEO Timothy Wilmott on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Oct 23, 1:30PM CDT

PENN: 13.94 (+0.79)

Penn National Gaming (PENN) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Oct 23, 8:55AM CDT

PENN: 13.94 (+0.79)

More on Penn National Gaming's Q3
Seeking Alpha - at Seeking Alpha - Thu Oct 23, 8:54AM CDT

PENN: 13.93 (+0.78)

Penn National Gaming tops Street 3Q forecasts
Automated Insights - Thu Oct 23, 7:12AM CDT
WYOMISSING, Pa. (AP) _ Penn National Gaming Inc. (PENN) on Thursday reported third-quarter earnings of $8.5 million.
PENN: 13.93 (+0.78)

Penn National beats by $0.04, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Oct 23, 6:07AM CDT

PENN: 13.93 (+0.78)

Penn National Gaming Reports Third Quarter Revenue of $645.9 Million and Adjusted EBITDA of $65.7 Million, Inclusive of $104.6 Million of Rent Expense
Business Wire - Thu Oct 23, 6:00AM CDT
Penn National Gaming, Inc. (PENN:Nasdaq):
PENN: 13.93 (+0.78)

Gambling Stock Roundup: Las Vegas Sands Posts In-Line Earnings, MGM Resorts and Others Work Toward Recovery - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 20, 12:49PM CDT
Las Vegas Sands Corp.'s third quarter earnings come in line with the Zacks Consensus Estimate while other companies continue to tread the recovery path.
CACQ: 9.85 (-0.46), PENN: 13.93 (+0.78), PNK: 22.55 (+0.01), BYD: 11.78 (+0.17), LVS: 61.44 (+1.96), CZR: 10.97 (-0.57), MGM: 22.48 (+0.34)

Halfway Through Construction Plainridge Park Casino is Far Exceeding Its Diversity Goals
Business Wire - Mon Oct 13, 11:01AM CDT
The Massachusetts Gaming Commission (MGC) reported recently that Penn National Gaming, Inc. (Nasdaq: PENN) (the "Company" or "Penn National"

has far exceeded its construction diversity vendor goals at the halfway point through construction of its $225 million Plainridge Park Casino.
PENN: 13.93 (+0.78)

Penn National Gaming Named Employer of First Choice in 14th Annual Bristol Associates/Spectrumetrix(TM) Executive Satisfaction Survey
Business Wire - Thu Oct 09, 9:00AM CDT
Penn National Gaming, Inc. (PENN: Nasdaq) ("Penn National" or the "Company"

announced today that Spectrum Gaming Group has named it the gaming industry's Employer of First Choice in the 14th Annual Bristol Associates/Spectrumetrix(TM) Executive Satisfaction Survey.
PENN: 13.93 (+0.78)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Swanson Nexus Pro Launch: Boost for Dietitians

By Lucas Young Updated Oct 24, 2026 Category News Views 184

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Alaska's Insurance Maze: Coverage Over Cheap Policies

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Ping An's Bold Green Moves Ahead of APEC 2026

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Likang's Bold Move: Cancer Immunotherapy at AD Summit

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Spooky Dining at CARNE: A Halloween Hit in Oxnard

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Apalutamide Boosts Outlook for Prostate Cancer Treatment

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

World Young Scientist Summit 2026 in Wenzhou Kicks Off

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Bio-Thera's New Data: A Game Changer for NSCLC?

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...